Imidapril HCl

CAS No. 89396-94-1

Imidapril HCl( TA-6366 )

Catalog No. M19235 CAS No. 89396-94-1

Imidapril HCl is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 2.6 nM, used for the treatment of hypertension.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 48 In Stock
25MG 86 In Stock
50MG 147 In Stock
100MG 219 In Stock
200MG 326 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Imidapril HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Imidapril HCl is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 2.6 nM, used for the treatment of hypertension.
  • Description
    Imidapril HCl is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 2.6 nM, used for the treatment of hypertension.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    TA-6366
  • Pathway
    GPCR/G Protein
  • Target
    Prostaglandin Receptor
  • Recptor
    ACE
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    89396-94-1
  • Formula Weight
    441.91
  • Molecular Formula
    C20H27N3O6·HCl
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 50 mg/mL 113.15 mM; H2O : 50 mg/mL 113.15 mM
  • SMILES
    CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@@H](CN(C2=O)C)C(=O)O.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Thoulon F, Woehrlé F, Boisramé B.J Vet Cardiol. 2003 May;5(1):29-34.
molnova catalog
related products
  • Pirmagrel

    pirmagrel is a potent thromboxane synthase inhibitor.

  • Travoprost

    Travoprost is used to treat glaucoma and ocular hypertensionis a potent and selective FP prostaglandin receptor agonist.

  • L-798106

    L-798106 (CM9) is a selective and potent prostaglandin-like EP3 receptor antagonist that inhibits EP4, EP1, and EP2 receptors, suppresses levels of pro-inflammatory cytokines in atherosclerosis, and attenuates PGE2-induced cough.